Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 4
2019 4
2020 4
2021 2
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Thermal Ablation versus SBRT in liver tumours: pros and cons.
Loi M, Desideri I, Dominici L, Francolini G, Garlatti P, Ciccone LP, Stocchi G, Salvestrini V, Meattini I, Livi L. Loi M, et al. Among authors: garlatti p. Med Oncol. 2020 Apr 29;37(6):52. doi: 10.1007/s12032-020-01377-7. Med Oncol. 2020. PMID: 32350765 Review.
PERSIAN trial (NCT05717660): an ongoing randomized trial testing androgen deprivation therapy, apalutamide and stereotactic body radiotherapy. An alternative "triplet" for oligometastatic hormone sensitive prostate cancer patients.
Francolini G, Porreca A, Facchini G, Santini D, Bruni A, Simoni N, Trovò M, Osti MF, Fornarini G, Sisani M, Di Cataldo V, Detti B, Garlatti P, Bertini N, Serni S, Minervini A, Livi L. Francolini G, et al. Among authors: garlatti p. Med Oncol. 2023 Dec 29;41(1):39. doi: 10.1007/s12032-023-02268-3. Med Oncol. 2023. PMID: 38157111 Clinical Trial.
Pattern of recurrence after stereotactic body radiotherapy for para-aortic oligo-recurrent prostate cancer, a multicentric analysis.
Francolini G, Garlatti P, Di Cataldo V, Triggiani L, Simoni N, Detti B, Lorenzetti V, Colombo F, Morelli V, Ganovelli M, Caprara L, Orsatti C, Burchini L, Frosini G, Bertini N, Loi M, Simontacchi G, Greto D, Desideri I, Meattini I, Livi L. Francolini G, et al. Among authors: garlatti p. Radiol Med. 2023 Nov;128(11):1423-1428. doi: 10.1007/s11547-023-01701-x. Epub 2023 Aug 19. Radiol Med. 2023. PMID: 37597125
Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative setting.
Francolini G, Stocchi G, Detti B, Di Cataldo V, Bruni A, Triggiani L, Guerini AE, Mazzola R, Cuccia F, Mariotti M, Salvestrini V, Garlatti P, Borghesi S, Ingrosso G, Bellavita R, Aristei C, Desideri I, Livi L. Francolini G, et al. Among authors: garlatti p. Radiol Med. 2022 Feb;127(2):206-213. doi: 10.1007/s11547-021-01435-8. Epub 2021 Nov 30. Radiol Med. 2022. PMID: 34850352
Impact of COVID-19 on workload burden of a complex radiotherapy facility.
Francolini G, Desideri I, Stocchi G, Ciccone LP, Salvestrini V, Garlatti P, Aquilano M, Greto D, Bonomo P, Meattini I, Scotti V, Scoccianti S, Simontacchi G, Livi L. Francolini G, et al. Among authors: garlatti p. Radiol Med. 2021 May;126(5):717-721. doi: 10.1007/s11547-021-01338-8. Epub 2021 Mar 1. Radiol Med. 2021. PMID: 33646520 Free PMC article.
Enhancement of Soft Tissue Sarcoma Cell Radiosensitivity by Poly(ADP-ribose) Polymerase-1 Inhibitors.
Mangoni M, Sottili M, Salvatore G, Meattini I, Desideri I, Greto D, Loi M, Becherini C, Garlatti P, Delli Paoli C, Dominici L, Gerini C, Scoccianti S, Bonomo P, Silvano A, Beltrami G, Campanacci D, Livi L. Mangoni M, et al. Among authors: garlatti p. Radiat Res. 2018 Nov;190(5):464-472. doi: 10.1667/RR15035.1. Epub 2018 Aug 1. Radiat Res. 2018. PMID: 30067444
Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719).
Francolini G, Detti B, Di Cataldo V, Garlatti P, Aquilano M, Allegra A, Lucidi S, Cerbai C, Ciccone LP, Salvestrini V, Stocchi G, Guerrieri B, Visani L, Loi M, Desideri I, Mangoni M, Meattini I, Livi L. Francolini G, et al. Among authors: garlatti p. Radiol Med. 2022 Aug;127(8):912-918. doi: 10.1007/s11547-022-01511-7. Epub 2022 Jun 28. Radiol Med. 2022. PMID: 35763249 Free PMC article. Clinical Trial.
Influence of age and subtype in outcome of operable liposarcoma.
Greto D, Saieva C, Loi M, Terziani F, Visani L, Garlatti P, Lo Russo M, Muntoni C, Becherini C, Topulli J, Campanacci D, Beltrami G, Scoccianti G, Muratori F, Bonomo P, Desideri I, Francolini G, Livi L. Greto D, et al. Among authors: garlatti p. Radiol Med. 2019 Apr;124(4):290-300. doi: 10.1007/s11547-018-0958-4. Epub 2018 Nov 12. Radiol Med. 2019. PMID: 30421387
16 results